Hôpital Calmette

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• COPD1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed3 trials

Lead sponsor

• Intergroupe Francophone de Cancerologie Thoracique1 trial
• Pulmonx Corporation1 trial
• Takeda1 trial

Closed trials

• Completed

  Zephyr Etude Post-Inscription (French Registry)

  NCT04517916· Pulmonx Corporation· Source

• Completed

  Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation

  NCT04233021· Phase 2· Intergroupe Francophone de Cancerologie Thoracique· Source

• Completed

  TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

  NCT04129502· Phase 3· Takeda· Source